Skip to main content

Leadership Transition at Novaturas Group: Aleksejs Kriscuks Assumes CEO Role

The Baltic tour operator Novaturas Group announces that effective from April 25 Aleksejs Kriscuks has been appointed Chief Executive Officer. He succeeds Ieva Galvydiene, who is leaving the company today to pursue new professional opportunities.  “We are pleased to welcome Aleksejs Kriscuks as CEO of Novaturas Group. With over 20 years of experience in the tourism sector and a strong track record across both travel agencies and tour operators, he brings deep operational expertise and proven leadership. We are confident that under his leadership, Novaturas will strengthen its position in the Baltics and continue to create sustainable value for its stakeholders,” says Gediminas Almantas, Chairman of the Board.  “Novaturas is a well-established and trusted brand in the Baltic region, with a strong team and loyal customer base. I am excited...

Continue reading

VEON Boosts Accessibility for Investors by Waiving Depositary Service Fees on American Depositary Shares

Dubai and New York, April 24, 2026 – VEON Ltd. (NASDAQ: VEON), a global digital operator (the “Company” or “VEON”), announces that, effective January 1, 2026, BNY Mellon will not collect depositary service fees (“DSF”) from investors that hold VEON’s American Depositary Shares (“ADSs”). The suspension of DSF charges for investors effectively reduces the cost of ownership by USD 0.05 per ADS per year and enhances accessibility for both existing and prospective investors. “VEON’s steps to reduce the cost of ownership of ADSs and introduce a capital allocation policy that targets to return at least USD 100 million annually through share buybacks are both responses to our ongoing dialogue with investors,” said Kaan Terzioglu, Chief Executive Officer of VEON. “At the same time, we continue to execute on our strategy to transform...

Continue reading

Shareholders of INVL Baltic Real Estate approved dividend allocation for the year 2025

The General Shareholders Meeting of INVL Baltic Real Estate (hereinafter – the Company) held on 24 April 2026 decided to approve the proposed dividend allocation of EUR 0.09 per share for the year 2025 (the total amount of dividends allocation amounts to EUR 0.714 million). The Company notes that dividends will be paid out and the dividend payment procedure for 2025 will be published within one month of the General Shareholders Meeting that approved the decision to allocate the dividends. Persons, who will be shareholders of the Company at the end of 11 May 2025, the tenth day after the General Shareholders Meeting to approve the resolution to allocate part of the Company’s profit for the payment of dividends, are entitled to receive dividends. The ex-date is 10 May 2026. From that date, the new owner of the shares of INVL Baltic Real...

Continue reading

Aspo to publish Interim Report for January-March 2026 on Monday, April 27, 2026

Aspo Plc Investor news April 24, 2026 at 9.45 EEST Aspo to publish Interim Report for January-March 2026 on Monday, April 27, 2026 Aspo Plc will publish its Interim Report for January-March 2026 on Monday, April 27, 2026, at approximately 9.00 a.m. EEST. A news conference for analysts, investors and the media will be held at Sanomatalo, Flik Studio Eliel, Töölönlahdenkatu 2, Helsinki on April 27, 2026, at 12.00 p.m. The event is also open to private investors. Participants are requested to register beforehand by emailing viestinta@aspo.com. The interim report will be presented by CEO Rolf Jansson and CFO Erkka Repo. The event will be held in English, and it can also be followed as a live webcast at https://aspo.events.inderes.com/q1-2026. Questions can be asked through a webcast form. A recording of the event will be available later the...

Continue reading

Digitalist Group Plc’s Business Review, 1 January – 31 March 2026

DIGITALIST GROUP PLC                    Stock Exchange Release 24.4.2026 at 9:00                                    Digitalist Group Plc’s Business Review, 1 January – 31 March 2026 January–March 2026 (comparable figures for 2025 in parentheses):Turnover: EUR 3.8 million (EUR 4.5 million), decrease of 14.0%. EBITDA: EUR -0.4 million (EUR -0.1 million), -10.6% of turnover (-3.0%). EBIT: EUR -0.5 million (EUR -0.3 million), -13.9% of turnover (-5.9%). Net income: EUR -1.3 million (EUR -1.0 million), -32.8% of turnover (-23.0%). Earnings per share (diluted and undiluted): EUR -0.45 (EUR -0.37).* Number of employees at the end of the review period: 120 (123), reduction of 2.4%.*The 2025 figures are presented on a comparable basis following the share consolidation on 15 August 2025. CEO’s review The first quarter of 2026 has been a challenging...

Continue reading

Invitation to the webinar on Eesti Energia’s 2026 Q1 unaudited financial results

Eesti Energia will publish its 2026 Q1 financial results and interim report on 30 April. The investor call to present the results will take place on 30 April at 11:00 London time, 12:00 Frankfurt time, and 13:00 Tallinn time. The conference call will be held in English. To participate, please join via the following link. A Q&A session will follow the presentation. As the webinar time is limited, we encourage participants to share their questions with us in advance at investor@enefit.com The report and the investor call presentation will be made available in the morning of 30 April on the Eesti Energia Investor Relations website. The recording and transcript of the call will be published on the same page afterwards. Further information:Danel FreibergHead of Treasury and Financial Risk ManagementEesti Energia ASTel: +372 5594 3838E...

Continue reading

Nilörn Interim Report Q1, 2026

Period January – MarchOrder intake decreased by 18 per cent and amounted to MSEK 218 (267), Adjusted for currency effects, the order intake decreased by 10 per cent. Net sales in SEK decreased by 16 per cent and amounted to MSEK 218 (259) Adjusted for currency effects of MSEK 24 and an order of MSEK 16 which this year will be delivered in Q2 (last year in Q1), revenue amounted to MSEK 258, corresponding to un unchanged growth Operating profit amounted to MSEK 15.4 (23.0) Adjusted for non-recurring costs of MSEK 2.3, operating profit amounted to MSEK 17.7 (23.0) Profit before tax amounted to MSEK 15.7 (20.9) Net profit for the period amounted to MSEK 12.2 (15.8) Earnings per share amounted to 1.07 (1.38) SEKSignificant events during the quarterThe Board of Directors has decided to propose an unchanged dividend of SEK 1.50 (1.50)...

Continue reading

Vaisala Corporation Interim Report January–March 2026: Industrial Measurements growth driving first quarter results

Vaisala Corporation        Interim Report January–March 2026        April 24, 2026, at 9:00 a.m. (EEST) Vaisala Corporation Interim Report January–March 2026: Industrial Measurements growth driving first quarter results This release is a summary of Vaisala’s Interim Report January–March 2026. The complete report is attached to this release as a pdf file. It is also available on the company website at https://www.vaisala.com/en/investors. First quarter 2026:        Orders received EUR 127.4 (121.4) million, increase 5%, in constant currencies 10% Order book at the end of the period EUR 197.2 (Dec 31, 2025: 185.8) million, increase 6% Annual recurring revenue* (ARR) EUR 58.2 (Dec 31, 2025: 57.1) million, increase 2% Net sales EUR 137.0 (135.6) million, increase 1%, in constant currencies 7% EBITA EUR 20.7 (20.5) million, 15.1 (15.1) %...

Continue reading

Flow Traders 1Q 2026 Trading Update

Flow Traders 1Q 2026 Trading Update Amsterdam, the Netherlands – Flow Traders Ltd. (Euronext: FLOW) announces its unaudited 1Q 2026 trading update. HighlightsFlow Traders recorded net trading income of €155.9m and total income of €157.7m in 1Q26, increases of 11.2% and 16.8% when compared to 1Q25, respectively. Both, Flow Traders’ ETP value traded and its total value traded increased by 27% year-on-year in 1Q26, to €644bn and €2,182bn respectively. Fixed operating expenses were €56.1m in the quarter, an increase of 10.5% when compared to 1Q25, driven by higher employee and technology expenses. Total operating expenses were €85.5m in 1Q26, an increase of 17.5% when compared to 1Q25, mostly due to higher variable employee expenses related to strong financial performance. EBITDA was €72.2m in the quarter, an increase of 15.9% when...

Continue reading

CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study

“Totality of evidence” approach to evaluate SCENESSE® EXECUTIVE SUMMARYfinal European scientific advice received for pivotal Phase III vitiligo study EMA emphasised its “totality of evidence” approach central photographic review and validated disease assessment tools agreed CUV107 to compare SCENESSE® with adjunct NB-UVB vs NB-UVB monotherapy CUV107 study (n=300) to commence in 2H 2026MELBOURNE, Australia, April 24, 2026 (GLOBE NEWSWIRE) — CLINUVEL PHARMACEUTICALS LTD today announced that the European Medicines Agency (EMA) has provided final scientific advice on the design of the planned pivotal Phase III CUV107 study and anticipated evaluation of evidence of CLINUVEL’s drug SCENESSE® (afamelanotide) as a systemic vitiligo treatment. EMA’s Scientific Advice¹ Following over 12 months of interaction, two formal submissions and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.